CD4 and cancer: Consistent with prior reviews, our investigation shows that high infiltration of CD8+ and CD4+ T-cells in the tumors influences inhibitory IC, and is associated with cytokine-receptor signaling pathways across cancers (Supplementary Figures S1 and S8).